Back To Schedule
Tuesday, September 20 • 2:15pm - 3:00pm
Panel: Focus on Accelerating Development and Pushing Targets into the Clinic

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

avatar for Scott Drutman, MD, PhD

Scott Drutman, MD, PhD

Senior Vice President, Head of Translational Science, Volastra Therapeutics
Scott is Senior Vice President, Head of Translational Science at Volastra Therapeutics. He is an oncologist physician scientist who is passionate about translating scientific discoveries into treatments for cancer patients. Prior to joining Volastra, Scott worked in oncology clinical... Read More →
avatar for Fouad Namouni, M.D.

Fouad Namouni, M.D.

President, Research & Development, Blueprint Medicines
Fouad brings more than 20 years of oncology and cancer immunotherapy drug development expertise, as well as clinical experience as a pediatric oncologist. Prior to joining Blueprint Medicines, Fouad served in leadership roles at Bristol-Myers Squibb (BMS) since 1999, including as... Read More →
avatar for Dennis Zaller, Ph.D.

Dennis Zaller, Ph.D.

Chief Scientific Officer, ROME Therapeutics
Dennis is Chief Scientific Officer at ROME Therapeutics and has more than 30 years of experience in the biopharma industry. Most recently, he spent five years as executive director, integrative sciences at Celgene (later Bristol Myers Squibb) in Cambridge, Mass. In this role, he provided... Read More →

Tuesday September 20, 2022 2:15pm - 3:00pm EDT